If Medicaid denies or delays GLP-1 coverage, understanding your genetic and metabolic baseline can help your provider recommend compounded alternatives that may offer similar efficacy at lower cost
Most people should expect mixed coverage: some commercial plans cover semaglutide for weight loss, many require prior authorization, Medicare still has major limits today, and Medicaid rules vary by state
[4] The starting dose is 0.25 mg once weekly for 4 weeks, then 0.5 mg weekly
Pediatric trials are quietly underway to support prescribing GLP-1 medications for obesity in children younger than 12, despite concerns about their long-term effects on developing bodies
Bolognesi, M., Amodio, P., Merkel, C., Godi, L., and Gatta, A
These impressive results have made Mounjaro a promising option for individuals struggling with obesity, even if they do not have type 2 diabetes